Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2026-01-04 @ 9:00 AM
Study NCT ID:
NCT00547261
Status:
TERMINATED
Last Update Posted:
2009-04-17
First Post:
2007-10-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TED5710
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
ICD Study Director
Old Organization:
sanofi-aventis